Author

P. C. Driscoll

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1 Research Focus:metabolism & bioenergetics· 1 Assay:metabolomics· 1

Frequent Co-Authors

A. Mendez-Lucas· 1 shared A. P. Snijders· 1 shared A. Theisen· 1 shared C. Xie· 1 shared D. Anastasiou· 1 shared F. Fraternali· 1 shared J. A. Macpherson· 1 shared J. I. MacRae· 1 shared

Activity by Year

2018-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Mendez-Lucas

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivJan 6, 2020

Identifying strategies to target the metabolic flexibility of tumours.

A. Mendez-Lucas, W. Lin, P. C. Driscoll…·M. Yuneva

The paper identifies compensatory metabolic mechanisms in tumours and shows that targeting these can improve therapeutic outcomes.

DOI 10.1038/s42255-020-0195-8

𝕏 PostBluesky

BiochemistrybioRxivJul 26, 2018

Functional cross-talk between allosteric effects of activating and inhibiting ligands underlies PKM2 regulation

J. A. Macpherson, A. Theisen, L. Masino…·D. Anastasiou

The paper investigates how PKM2 activity is regulated by simultaneous binding of activating and inhibiting ligands, revealing a mechanism for integrating allosteric inputs.

DOI 10.7554/elife.45068

statistical modelprotein folding & dynamics

𝕏 PostBluesky